ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report

An unvaccinated adult male heart transplant recipient patient with recalcitrant COVID-19 due to SARS-CoV-2 delta variant with rising nasopharyngeal quantitative viral load was successfully treated with ALVR109, an off-the-shelf SARS-CoV-2–specific T cell therapy. Background immunosuppression include...

Descripción completa

Detalles Bibliográficos
Autores principales: Martits-Chalangari, Katalin, Spak, Cedric W., Askar, Medhat, Killian, Aaron, Fisher, Tammy L., Atillasoy, Ercem, Marshall, William L., McNeel, David, Miller, Michael D., Mathai, Susan K., Gottlieb, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303326/
https://www.ncbi.nlm.nih.gov/pubmed/34910857
http://dx.doi.org/10.1111/ajt.16927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303326/
https://www.ncbi.nlm.nih.gov/pubmed/34910857
http://dx.doi.org/10.1111/ajt.16927

Ejemplares similares